Curran Simpson, Chief Executive Officer at REGENXBIO Inc. (RGNX), sold 19,296 shares at $15.04 ($290K) on 2024-07-29, disclosed to the SEC on 2024-07-30.
Scheduled sale ($290k) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.04 | 9,648 | $145K | 50.0% |
| 2 | $15.04 | 9,648 | $145K | 50.0% |
| Total | $15.04 avg | 19,296 | $290K | 100% |
| Filing → |
| RGNX | SELL | 2025-09-12 | $155K | — | Filing → |
| RGNX | SELL | 2024-08-05 | $2K | — | Filing → |
| RGNX | SELL | 2021-01-14 | $1.2M | — | Filing → |